These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1347453)

  • 1. Somatostatin and growth hormone regulation in cancer.
    Manni A
    Biotherapy; 1992; 4(1):31-6. PubMed ID: 1347453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future.
    Öberg K; Lamberts SW
    Endocr Relat Cancer; 2016 Dec; 23(12):R551-R566. PubMed ID: 27697899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of refractory prostate cancer with somatostatin analogues and glucocorticoids.
    Trafalis DT; Athanassiou AE
    J BUON; 2008; 13(2):295-6. PubMed ID: 18555482
    [No Abstract]   [Full Text] [Related]  

  • 4. [Somatostatin analogs in the combined treatment of patients with hormone-resistant prostate cancer].
    Kaprin AD; Gafanov PA; Fastovets SV
    Vopr Onkol; 2009; 55(4):474-6. PubMed ID: 19947374
    [No Abstract]   [Full Text] [Related]  

  • 5. Somatostatin analogues in the treatment of breast and prostate cancer.
    Manni A; Boucher AE; Demers LM; Harvey HA; Lipton A; Simmonds MA; Bartholomew M
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1083-7. PubMed ID: 1981012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of somatostatin analogues in complete antiandrogen treatment in patients with prostatic carcinoma.
    Vainas G; Pasaitou V; Galaktidou G; Maris K; Christodoulou K; Constantinidis C; Kortsaris AH
    J Exp Clin Cancer Res; 1997 Mar; 16(1):119-26. PubMed ID: 9148872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I study of the somatostatin analogue somatuline in patients with metastatic hormone-refractory prostate cancer.
    Figg WD; Thibault A; Cooper MR; Reid R; Headlee D; Dawson N; Kohler DR; Reed E; Sartor O
    Cancer; 1995 Apr; 75(8):2159-64. PubMed ID: 7535186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term pre-surgical treatment with somatostatin analogues, octreotide and lanreotide, in acromegaly.
    Waśko R; Ruchała M; Sawicka J; Kotwicka M; Liebert W; Sowiński J
    J Endocrinol Invest; 2000 Jan; 23(1):12-8. PubMed ID: 10698045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin and analogues in the treatment of cancer. A review.
    Evers BM; Parekh D; Townsend CM; Thompson JC
    Ann Surg; 1991 Mar; 213(3):190-8. PubMed ID: 1671812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
    Schally AV; Redding TW
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7275-9. PubMed ID: 2890164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative potencies of the somatostatin analogs octreotide, BIM-23014, and RC-160 on the inhibition of hormone release by cultured human endocrine tumor cells and normal rat anterior pituitary cells.
    Hofland LJ; van Koetsveld PM; Waaijers M; Zuyderwijk J; Lamberts SW
    Endocrinology; 1994 Jan; 134(1):301-6. PubMed ID: 7903931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of metastatic breast cancer with somatostatin analogues--a meta-analysis.
    Dolan JT; Miltenburg DM; Granchi TS; Miller CC; Brunicardi FC
    Ann Surg Oncol; 2001 Apr; 8(3):227-33. PubMed ID: 11314939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin and somatostatin analogues in human breast carcinoma.
    Prévost G; Israel L
    Recent Results Cancer Res; 1993; 129():63-70. PubMed ID: 8102489
    [No Abstract]   [Full Text] [Related]  

  • 14. Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumors.
    Delaunoit T; Rubin J; Neczyporenko F; Erlichman C; Hobday TJ
    Mayo Clin Proc; 2005 Apr; 80(4):502-6. PubMed ID: 15819288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical use of somatostatin analogues in the treatment of cancer.
    Lamberts SW; Krenning EP; Klijn JG; Reubi JC
    Baillieres Clin Endocrinol Metab; 1990 Mar; 4(1):29-49. PubMed ID: 1975166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin analogue treatment of neuroendocrine tumours.
    de Herder WW; van der Lely AJ; Lamberts SW
    Postgrad Med J; 1996 Jul; 72(849):403-8. PubMed ID: 8935599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors.
    Shimon I; Yan X; Taylor JE; Weiss MH; Culler MD; Melmed S
    J Clin Invest; 1997 Nov; 100(9):2386-92. PubMed ID: 9410919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Somatostatin analogs in oncology].
    Thomas F; Parmar H; Prevost G; Kuhn JM; Bejot JL; Moreau JP; Bogden A
    Bull Cancer; 1991; 78(8):693-707. PubMed ID: 1681967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas.
    Saveanu A; Gunz G; Dufour H; Caron P; Fina F; Ouafik L; Culler MD; Moreau JP; Enjalbert A; Jaquet P
    J Clin Endocrinol Metab; 2001 Jan; 86(1):140-5. PubMed ID: 11231991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of analogs of LH-RH and somatostatin for the treatment of hormone dependent cancers.
    Redding TW; Schally AV
    Prog Clin Biol Res; 1988; 262():217-40. PubMed ID: 2897695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.